Bladder Cancer Field Looking Toward Immunotherapy Combos to Improve Responses, Apolo Says – Targeted Oncology
Targeted Oncology |
Bladder Cancer Field Looking Toward Immunotherapy Combos to Improve Responses, Apolo Says
Targeted Oncology And although clinical activity is promising with the single agent, Andrea Apolo, MD, says that clinical trials in bladder cancer are moving toward combinations, which she says will improve on the already impressive progress made so far with … |
